Patients should be counseled to: Consume smaller, more frequent meals (56 per day) rather than large portions Emphasize low-fat, low-fiber foods that empty more readily from the stomach Ensure adequate hydration, particularly with liquid calories if solid food tolerance is poor Avoid lying down immediately after meals Chew food thoroughly and eat slowly For patients developing concerning symptoms, temporary dose reduction or treatment interruption may be necessary
This question is increasingly relevant as tirzepatide (Mounjaro, Zepbound) gains prominence in managing type 2 diabetes and obesity
Although DPP-4 inhibitors are known to have a very low risk for hypoglycemia based on their mechanism of action, the concomitant use of a sulfonylurea increases the hypoglycemia risk [43]
Mechanism of Action (Based on Preclinical and Experimental Research) Telomerase activation: Research models suggest Epithalon may stimulate the expression of Telomerase, an enzyme responsible for maintaining telomere length at the ends of chromosomes
When in doubt, its better to err on the side of caution
